Compare DuPont de Nemours Inc (DD) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs MakeMyTrip Ltd — how do they compare? DuPont de Nemours Inc trades at $130 (market cap $17.89B), while MakeMyTrip Ltd trades at $44.73 (market cap $4.09B). The key difference: DuPont de Nemours Inc is far larger — about 4.4× MakeMyTrip Ltd's market cap, and DuPont de Nemours Inc pays a 1.81% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold DuPont de Nemours Inc for 89 Days and MakeMyTrip Ltd for 12 Days on average.
| DD | MMYT | |
|---|---|---|
Market Cap | $17.89B | $4.09B |
Volume | 816,409 | 1,828,010 |
Sector | Basic Materials | Consumer Cyclical |
52-Week High | $154.59 | $92.25 |
52-Week Low | $92.49 | $36.30 |
Typical Hold Time | 89 Days | 12 Days |
Enterprise Value | $19.28B | $4.75B |
Dividend Yield | 1.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $132.48, up 1.07% with neutral technical signals. The company shows mixed fundamentals with strong recent earnings beats but declining revenue from $12.4B in 2024 to $6.85B in 2025, resulting in a net loss of $779M. Analyst consensus is bullish with 59% buy ratings, though the $95 consensus price target suggests downside risk. Recent developments include new product launches in sustainable materials and digital tools, alongside ongoing legal settlements related to PFAS contamination.
Outlook remains cautious due to revenue contraction and margin pressure, offset by innovation in high-growth sectors like healthcare and water technologies. Key risks include legal liabilities from PFAS lawsuits and volatile cash flows, while institutional sentiment appears divided with recent stake reductions by several funds.
MakeMyTrip (MMYT) trades at $43.53, up 0.28% with a bearish technical outlook despite strong analyst consensus. The company reported mixed quarterly earnings with Q1 2026 beating expectations but Q4 2025 and Q2 2026 missing estimates. Revenue grew to $978 million in 2025 with a net income margin of 3.23%, though profitability declined in 2026. The stock carries a high P/E of 189.17 but shows positive cash flow generation and a healthy balance sheet with $761 million in cash.
MMYT presents a compelling growth story with 72.7% analyst buy ratings and a $77 price target suggesting 77% upside. However, execution risks persist amid volatile earnings, declining 2026 profitability, and technical bearish signals. The planned Indian subsidiary IPO could unlock value, but investors face near-term volatility from mixed financial performance and institutional selling pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
